Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.75p +9.38% 20.40p 20.40p 20.80p 21.00p 18.80p 18.80p 13,630,396 16:29:52
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 76

Circassia Pharmaceuticals Plc Holding(s) in Company

28/05/2019 5:58pm

UK Regulatory (RNS & others)


TIDMCIR

RNS Number : 3874A

Circassia Pharmaceuticals Plc

28 May 2019

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible)(i) 
 
 1a. Identity of the issuer or the                                   Circassia Pharmaceuticals PLC 
  underlying issuer of existing shares 
  to which voting rights are attached(ii) 
  : 
                                                             -------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                     ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights 
                                                                                                     ---- 
 An acquisition or disposal of financial instruments 
                                                                                                     ---- 
 An event changing the breakdown of voting rights 
                                                                                                     ---- 
 Other (please specify)(iii) :                                                                         X 
  Massachusetts Mutual Life Insurance Company ("MassMutual"), an indirect 
  corporate parent of OppenheimerFunds, Inc. ("OFI") and its subsidiaries, 
  sold OFI to Invesco Ltd. ("Invesco") in a transaction that closed 
  on May 24, 2019. As a result, investment discretion and voting rights 
  previously exercised by OFI over its various mutual funds and other 
  accounts has been transferred to Invesco. OFI no longer holds any 
  disclosable position in the issuer. 
                                                                                                     ---- 
 3. Details of person subject to the notification obligation(iv) 
 Name                                                         OppenheimerFunds, Inc. 
 City and country of registered office                        225 Liberty Street, New York, New 
  (if applicable)                                              York, 10281, United States 
 4. Full name of shareholder(s) (if different from 3.)(v) 
 Name 
                                                             -------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                             -------------------------------------------- 
 5. Date on which the threshold was                           24 May 2019 
  crossed or reached(vi) : 
                                                             -------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):               24 May 2019 
                                                             -------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights    Total of both   Total number 
                            rights attached      through financial     in % (8.A +     of voting rights 
                            to shares (total        instruments            8.B)        of issuer(vii) 
                                of 8. A)           (total of 8.B 
                                                    1 + 8.B 2) 
                          ------------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached                     0.00%                                    0.00%           375,048,054 
                          ------------------  ---------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)                    9.79%                                    9.79% 
                          ------------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on 
  which the threshold was crossed or reached(viii) 
 A: Voting rights attached to shares 
 Class/type of     Number of voting rights(ix)                    % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                  ---------------------------------------------  ----------------------------------------------- 
                          Direct                Indirect                  Direct                 Indirect 
                    (Art 9 of Directive    (Art 10 of Directive     (Art 9 of Directive     (Art 10 of Directive 
                       2004/109/EC)            2004/109/EC)        2004/109/EC) (DTR5.1)        2004/109/EC) 
                         (DTR5.1)               (DTR5.2.1)                                       (DTR5.2.1) 
                  ---------------------  ----------------------  -----------------------  ---------------------- 
 GB00BFXZC448                             0.00                                             0.00% 
                  ---------------------  ----------------------  -----------------------  ---------------------- 
 
 SUBTOTAL 8. A                         0.00                                           0.00% 
                  ---------------------------------------------  ----------------------------------------------- 
 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 
  2004/109/EC (DTR5.3.1.1 (a)) 
 Type of financial   Expiration   Exercise/                Number of voting        % of voting 
  instrument          date(x)      Conversion Period(xi)    rights that may         rights 
                                                            be acquired if 
                                                            the instrument 
                                                            is 
                                                            exercised/converted. 
                    -----------  -----------------------  ----------------------  ------------ 
 
                                  SUBTOTAL 8. B 1 
                                 -----------------------  ----------------------  ------------ 
 
 
 B 2: Financial Instruments with similar economic effect according 
  to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of financial   Expiration   Exercise/      Physical or        Number of        % of voting 
  instrument          date(x)      Conversion     cash               voting rights    rights 
                                   Period (xi)    settlement(xii) 
                    -----------  -------------  -----------------  ---------------  ------------ 
 
                                                 SUBTOTAL 8.B.2 
                                                -----------------  ---------------  ------------ 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                 X 
  by any natural person or legal entity and does not control 
  any other undertaking(s) holding directly or indirectly an 
  interest in the (underlying) issuer(xiii) 
 Full chain of controlled undertakings through which the voting 
  rights and/or the 
  financial instruments are effectively held starting with 
  the ultimate controlling natural person or legal entity(xiv) 
  (please add additional rows as necessary) 
    Name(xv)        % of voting rights      % of voting rights      Total of both 
                      if it equals or        through financial      if it equals or 
                     is higher than the      instruments if it      is higher than 
                    notifiable threshold    equals or is higher     the notifiable 
                                            than the notifiable        threshold 
                                                 threshold 
                  ----------------------  ---------------------  ------------------- 
 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                          ------------------------------------------ 
 The number and % of voting rights 
  held 
                                          ------------------------------------------ 
 The date until which the voting 
  rights will be held 
                                          ------------------------------------------ 
 
 11. Additional information(xvi) 
 
 
 
 
 Place of completion   Oxford 
 Date of completion    28 May 2019 
                      ------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUWVNRKSAVUAR

(END) Dow Jones Newswires

May 28, 2019 12:58 ET (16:58 GMT)

1 Year Circassia Pharmaceuticals Chart

1 Year Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190720 05:25:08